<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
         xmlns="http://purl.org/rss/1.0/"
         xmlns:admin="http://webns.net/mvcb/"
         xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
         xmlns:dc="http://purl.org/dc/elements/1.1/"
         xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">
  <channel rdf:about="https://hstalks.com/rss/by-therapeutic-area/7/">
    <title>Neurology</title>
    <link>https://hstalks.com/therapeutic-area/7/neurology/?biosci</link>
    <description>New and updated series &amp; talks on Neurology from HSTalks&#x27; Biomedical &amp; Life Sciences Collection.</description>
    <admin:generatorAgent rdf:resource="http://www.hstalks.com/" />
    <admin:errorReportsTo rdf:resource="mailto:info@hstalks.com" />
    <sy:updatePeriod>daily</sy:updatePeriod>
    <sy:updateFrequency>1</sy:updateFrequency>
    <sy:updateBase>2006-01-01T12:00+00:00</sy:updateBase>
    <dc:publisher>Henry Stewart Talks</dc:publisher>
    <dc:language>en</dc:language>
    <dc:rights>© Copyright Henry Stewart Talks Ltd.</dc:rights>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
    <prism:copyright>© Copyright Henry Stewart Talks Ltd.</prism:copyright>
    <items>
      <rdf:Seq>
      <rdf:li resource="https://hstalks.com/t/25892/pain-mechanisms-and-perception/?biosci" />
      <rdf:li resource="https://hstalks.com/t/25891/central-nervous-system/?biosci" />
      <rdf:li resource="https://hstalks.com/t/23356/duchenne-muscular-dystrophy-advances-in-research-t/?biosci" />
      <rdf:li resource="https://hstalks.com/t/21277/technology-for-individuals-with-autism-spectrum-di/?biosci" />
      <rdf:li resource="https://hstalks.com/t/23389/unlocking-a-cryptic-pocket-a-new-approach-to-safer/?biosci" />
      <rdf:li resource="https://hstalks.com/t/24732/facial-muscles-and-innervation/?biosci" />
      <rdf:li resource="https://hstalks.com/t/24740/mental-health-nursing/?biosci" />
      <rdf:li resource="https://hstalks.com/t/20584/cell-replacement-therapy-for-neurodegenerative-dis/?biosci" />
      <rdf:li resource="https://hstalks.com/t/18670/pathophysiology-and-management-of-chronic-inflamma/?biosci" />
      <rdf:li resource="https://hstalks.com/t/20617/cell-replacement-therapy-for-neurodegenerative-dis/?biosci" />
      <rdf:li resource="https://hstalks.com/t/19957/interpreting-non-clinical-toxicity-studies-in-psyc/?biosci" />
      <rdf:li resource="https://hstalks.com/t/22300/duchenne-muscular-dystrophy-pathology-diagnostic-s/?biosci" />
      <rdf:li resource="https://hstalks.com/t/22532/action-potentials-and-synaptic-transmission/?biosci" />
      <rdf:li resource="https://hstalks.com/t/20089/brain-aging-at-a-crossroads-where-do-we-go-from-th/?biosci" />
      <rdf:li resource="https://hstalks.com/t/22533/neurodevelopment-and-disorders/?biosci" />
      
      </rdf:Seq>
    </items>
  </channel>

  <item rdf:about="https://hstalks.com/t/25892/pain-mechanisms-and-perception/?biosci">
    <title>Pain mechanisms and perception [4 mins] </title>
    <link>https://hstalks.com/t/25892/pain-mechanisms-and-perception/?biosci</link>
    <description>Pain definitions and classification - Pain mechanisms and types - Nociceptors and pain pathways - Brain regions in pain perception - Psychological and biological pain factors - Pain threshold, tolerance, sensitization - Multimodal pain management strategies</description>
    <dc:title>Pain mechanisms and perception</dc:title>
    
    
    <dc:subject>Pain definitions and classification, Pain mechanisms and types, Nociceptors and pain pathways, Brain regions in pain perception, Psychological and biological pain factors, Pain threshold, tolerance, sensitization, Multimodal pain management strategies</dc:subject>
    <dc:date>2026-08-31</dc:date>
    <prism:publicationDate>2026-08-31</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/25891/central-nervous-system/?biosci">
    <title>Central nervous system [4 mins] </title>
    <link>https://hstalks.com/t/25891/central-nervous-system/?biosci</link>
    <description>CNS anatomy basics - Brain and spinal cord - CNS protective structures - Brain regions and functions - Neural communication mechanisms - Sensory integration and coordination - CNS in homeostasis regulation - CNS impact on behavior and cognition</description>
    <dc:title>Central nervous system</dc:title>
    
    
    <dc:subject>CNS anatomy basics, Brain and spinal cord, CNS protective structures, Brain regions and functions, Neural communication mechanisms, Sensory integration and coordination, CNS in homeostasis regulation, CNS impact on behavior and cognition</dc:subject>
    <dc:date>2026-08-31</dc:date>
    <prism:publicationDate>2026-08-31</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/23356/duchenne-muscular-dystrophy-advances-in-research-t/?biosci">
    <title>Duchenne muscular dystrophy: advances in research, treatment, and clinical management [13 mins] </title>
    <link>https://hstalks.com/t/23356/duchenne-muscular-dystrophy-advances-in-research-t/?biosci</link>
    <description>Duchenne muscular dystrophy causes and management - Dystrophin - Rare disease - Muscle wasting - Approved therapies for Duchenne</description>
    <dc:title>Duchenne muscular dystrophy: advances in research, treatment, and clinical management</dc:title>
    
    <dc:creator>Prof. Annemieke Aartsma-Rus</dc:creator>
    
    <dc:subject>Duchenne muscular dystrophy causes and management, Dystrophin, Rare disease, Muscle wasting, Approved therapies for Duchenne</dc:subject>
    <dc:date>2026-08-31</dc:date>
    <prism:publicationDate>2026-08-31</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/21277/technology-for-individuals-with-autism-spectrum-di/?biosci">
    <title>Technology for individuals with autism spectrum disorders [23 mins] </title>
    <link>https://hstalks.com/t/21277/technology-for-individuals-with-autism-spectrum-di/?biosci</link>
    <description>Assistive technology - SETT - Visual supports - Executive function skills and behavior - Technology for reading, writing and note taking - Upcoming technologies</description>
    <dc:title>Technology for individuals with autism spectrum disorders</dc:title>
    
    <dc:creator>Dr. Bogdan Zamfir</dc:creator>
    
    <dc:subject>Assistive technology, SETT, Visual supports, Executive function skills and behavior, Technology for reading, writing and note taking, Upcoming technologies</dc:subject>
    <dc:date>2026-08-31</dc:date>
    <prism:publicationDate>2026-08-31</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/23389/unlocking-a-cryptic-pocket-a-new-approach-to-safer/?biosci">
    <title>Unlocking a cryptic pocket: a new approach to safer pain relief [8 mins] </title>
    <link>https://hstalks.com/t/23389/unlocking-a-cryptic-pocket-a-new-approach-to-safer/?biosci</link>
    <description>CB1 receptor agonists - Cryptic pocket drug design - Molecular dynamics simulations - Peripheral pain therapeutics - Biased GPCR signalling - Tolerance reduction in cannabinoid therapies - Allosteric/sodium binding sites - Translation of analgesic drug candidates (VIP36) to the clinic</description>
    <dc:title>Unlocking a cryptic pocket: a new approach to safer pain relief</dc:title>
    
    <dc:creator>Prof. Susruta Majumdar</dc:creator>
    <dc:creator>Dr. Vipin Ashok Rangari</dc:creator>
    
    <dc:subject>CB1 receptor agonists, Cryptic pocket drug design, Molecular dynamics simulations, Peripheral pain therapeutics, Biased GPCR signalling, Tolerance reduction in cannabinoid therapies, Allosteric/sodium binding sites, Translation of analgesic drug candidates (VIP36) to the clinic</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/24732/facial-muscles-and-innervation/?biosci">
    <title>Facial muscles and innervation [3 mins] </title>
    <link>https://hstalks.com/t/24732/facial-muscles-and-innervation/?biosci</link>
    <description>Facial muscle anatomy - Muscle function and expressions - Facial nerve structure - Major facial muscles roles - Facial muscle disorders - Clinical signs and diagnosis - Central vs peripheral nerve lesions</description>
    <dc:title>Facial muscles and innervation</dc:title>
    
    
    <dc:subject>Facial muscle anatomy, Muscle function and expressions, Facial nerve structure, Major facial muscles roles, Facial muscle disorders, Clinical signs and diagnosis, Central vs peripheral nerve lesions</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/24740/mental-health-nursing/?biosci">
    <title>Mental health nursing [4 mins] </title>
    <link>https://hstalks.com/t/24740/mental-health-nursing/?biosci</link>
    <description>Intro to Mental Health Nursing - Assessment Techniques - Therapeutic Communication - Person-Centred Care - Crisis Intervention - Teamwork in Mental Health Nursing</description>
    <dc:title>Mental health nursing</dc:title>
    
    
    <dc:subject>Intro to Mental Health Nursing, Assessment Techniques, Therapeutic Communication, Person-Centred Care, Crisis Intervention, Teamwork in Mental Health Nursing</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/20584/cell-replacement-therapy-for-neurodegenerative-dis/?biosci">
    <title>Cell replacement therapy for neurodegenerative diseases 1 [40 mins] </title>
    <link>https://hstalks.com/t/20584/cell-replacement-therapy-for-neurodegenerative-dis/?biosci</link>
    <description>Overview of cell replacement therapies - Parkinsons’s disease (PD) and current treatments - Parkinson’s graft model - Dopamine grafts improve motor deficits - First PD clinical trials with fetal grafts - Generating stem cell derived dopamine neurons - Stem cell dopamine grafts - First-in-person clinical trials</description>
    <dc:title>Cell replacement therapy for neurodegenerative diseases 1</dc:title>
    
    <dc:creator>Dr. Mariah J. Lelos</dc:creator>
    
    <dc:subject>Overview of cell replacement therapies, Parkinsons’s disease (PD) and current treatments, Parkinson’s graft model, Dopamine grafts improve motor deficits, First PD clinical trials with fetal grafts, Generating stem cell derived dopamine neurons, Stem cell dopamine grafts, First-in-person clinical trials</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/18670/pathophysiology-and-management-of-chronic-inflamma/?biosci">
    <title>Pathophysiology and management of chronic inflammatory demyelinating polyneuropathy [26 mins] </title>
    <link>https://hstalks.com/t/18670/pathophysiology-and-management-of-chronic-inflamma/?biosci</link>
    <description>Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) - CIDP pathology - CIDP immunopathogenesis - CIDP treatment goals - Intravenous immunoglobulin (IVIG) - Plasma exchange (PLEX) - Corticosteroid (CSS) - Subcutaneous immunoglobulin (SCIG) - Neonatal Fc receptor inhibitors - Complement inhibitors</description>
    <dc:title>Pathophysiology and management of chronic inflammatory demyelinating polyneuropathy</dc:title>
    
    <dc:creator>Prof. Urvi Desai</dc:creator>
    
    <dc:subject>Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), CIDP pathology, CIDP immunopathogenesis, CIDP treatment goals, Intravenous immunoglobulin (IVIG), Plasma exchange (PLEX), Corticosteroid (CSS), Subcutaneous immunoglobulin (SCIG), Neonatal Fc receptor inhibitors, Complement inhibitors</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/20617/cell-replacement-therapy-for-neurodegenerative-dis/?biosci">
    <title>Cell replacement therapy for neurodegenerative diseases 2 [21 mins] </title>
    <link>https://hstalks.com/t/20617/cell-replacement-therapy-for-neurodegenerative-dis/?biosci</link>
    <description>Huntington’s disease (HD) - Genetics, symptoms and pathology of HD - Transplants in HD - Stem cell derived medium spiny neurons - hPSC-derived medium spiny neurons</description>
    <dc:title>Cell replacement therapy for neurodegenerative diseases 2</dc:title>
    
    <dc:creator>Dr. Mariah J. Lelos</dc:creator>
    
    <dc:subject>Huntington’s disease (HD), Genetics, symptoms and pathology of HD, Transplants in HD, Stem cell derived medium spiny neurons, hPSC-derived medium spiny neurons</dc:subject>
    <dc:date>2026-07-30</dc:date>
    <prism:publicationDate>2026-07-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/19957/interpreting-non-clinical-toxicity-studies-in-psyc/?biosci">
    <title>Interpreting non-clinical toxicity studies in psychiatric drug development: human relevance and safety [16 mins] </title>
    <link>https://hstalks.com/t/19957/interpreting-non-clinical-toxicity-studies-in-psyc/?biosci</link>
    <description>Psychiatric drug development - Challenges in early drug development - Challenges associated with lifelong treatment - Non-clinical toxicity studies - Toxicity studies for psychiatric therapeutics - Relevance to human safety</description>
    <dc:title>Interpreting non-clinical toxicity studies in psychiatric drug development: human relevance and safety</dc:title>
    
    <dc:creator>Dr. Yael Mandelblat-Cerf</dc:creator>
    
    <dc:subject>Psychiatric drug development, Challenges in early drug development, Challenges associated with lifelong treatment, Non-clinical toxicity studies, Toxicity studies for psychiatric therapeutics, Relevance to human safety</dc:subject>
    <dc:date>2026-06-30</dc:date>
    <prism:publicationDate>2026-06-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/22300/duchenne-muscular-dystrophy-pathology-diagnostic-s/?biosci">
    <title>Duchenne muscular dystrophy: pathology, diagnostic strategies, and core molecular pathways [14 mins] </title>
    <link>https://hstalks.com/t/22300/duchenne-muscular-dystrophy-pathology-diagnostic-s/?biosci</link>
    <description>Duchenne muscular dystrophy (DMD) pathology - Dystrophin structure and function - DMD genetics - Muscle degeneration - Fibrosis progression - Cardiomyopathy in DMD - Exon skipping therapy - Genetic diagnosis - Early intervention</description>
    <dc:title>Duchenne muscular dystrophy: pathology, diagnostic strategies, and core molecular pathways</dc:title>
    
    <dc:creator>Prof. Steve Wilton</dc:creator>
    
    <dc:subject>Duchenne muscular dystrophy (DMD) pathology, Dystrophin structure and function, DMD genetics, Muscle degeneration, Fibrosis progression, Cardiomyopathy in DMD, Exon skipping therapy, Genetic diagnosis, Early intervention</dc:subject>
    <dc:date>2026-06-30</dc:date>
    <prism:publicationDate>2026-06-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/22532/action-potentials-and-synaptic-transmission/?biosci">
    <title>Action potentials and synaptic transmission [4 mins] </title>
    <link>https://hstalks.com/t/22532/action-potentials-and-synaptic-transmission/?biosci</link>
    <description>Resting membrane potential - Action potential phases - Myelination and refractory periods - Synaptic transmission mechanisms - Postsynaptic integration - Effects of drugs and diseases on neural signals</description>
    <dc:title>Action potentials and synaptic transmission</dc:title>
    
    
    <dc:subject>Resting membrane potential, Action potential phases, Myelination and refractory periods, Synaptic transmission mechanisms, Postsynaptic integration, Effects of drugs and diseases on neural signals</dc:subject>
    <dc:date>2026-06-30</dc:date>
    <prism:publicationDate>2026-06-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/20089/brain-aging-at-a-crossroads-where-do-we-go-from-th/?biosci">
    <title>Brain aging at a crossroads: where do we go from three decades of failed therapeutics? [37 mins] </title>
    <link>https://hstalks.com/t/20089/brain-aging-at-a-crossroads-where-do-we-go-from-th/?biosci</link>
    <description>Oxidative stress - Possible mechanism of oxidative damage - Change in mitochondria in Alzheimer’s disease - Amyloid precursor protein (APP) induced mitochondrial abnormalities - Amyloid β and oxidative damage - NFT and oxidative damage - Metal binding and oxidation of amyloid β - Metalloproteins in AD - Role of amyloid β in metal-mediated radical formation</description>
    <dc:title>Brain aging at a crossroads: where do we go from three decades of failed therapeutics?</dc:title>
    
    <dc:creator>Prof. George Perry</dc:creator>
    
    <dc:subject>Oxidative stress, Possible mechanism of oxidative damage, Change in mitochondria in Alzheimer’s disease, Amyloid precursor protein (APP) induced mitochondrial abnormalities, Amyloid β and oxidative damage, NFT and oxidative damage, Metal binding and oxidation of amyloid β, Metalloproteins in AD, Role of amyloid β in metal-mediated radical formation</dc:subject>
    <dc:date>2026-06-30</dc:date>
    <prism:publicationDate>2026-06-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

  <item rdf:about="https://hstalks.com/t/22533/neurodevelopment-and-disorders/?biosci">
    <title>Neurodevelopment and disorders [4 mins] </title>
    <link>https://hstalks.com/t/22533/neurodevelopment-and-disorders/?biosci</link>
    <description>Neurodevelopment stages - Genetic and environmental factors - Neurogenesis, synaptogenesis, critical periods - Neurodevelopmental disorders causes - Early identification and intervention - Plasticity and prevention in neurodevelopment</description>
    <dc:title>Neurodevelopment and disorders</dc:title>
    
    
    <dc:subject>Neurodevelopment stages, Genetic and environmental factors, Neurogenesis, synaptogenesis, critical periods, Neurodevelopmental disorders causes, Early identification and intervention, Plasticity and prevention in neurodevelopment</dc:subject>
    <dc:date>2026-06-30</dc:date>
    <prism:publicationDate>2026-06-30</prism:publicationDate>
    <prism:publicationName>The Biomedical &amp; Life Sciences Collection</prism:publicationName>
  </item>

</rdf:RDF>
